4-Methyl-3-nitro-benzoic acid, a migration inhibitor, prevents breast cancer metastasis in SCID mice

Cancer Letters

Volumn 305, Issue 1, 2011, Pages 69-75

  Guo, Hua ^a   Li, Menghui ^a   Chen, Peng ^a   Blake, David J ^a   Kong, Xiaoni ^a   Hao, Xishan ^a   Niu, Ruifang ^a   Zhang, Ning ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Cell migration inhibitor; Metastasis; Paclitaxel

Indexed keywords

4 METHYL 3 NITRO BENZOIC ACID; ANTIMETASTATIC AGENT; EPIDERMAL GROWTH FACTOR; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CONTROL; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE REGULATION; CELL MIGRATION; CELL VIABILITY; CHEMOTAXIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; MICE, SCID; NEOPLASM METASTASIS; NITROBENZOATES; PACLITAXEL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 79953169087     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.02.028     Document Type: Article

References (37)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2002, 55(2005):74-108.
2. Parkin D.M., Fernandez L.M. Use of statistics to assess the global burden of breast cancer. Breast J. 2006, 12(Suppl. 1):S70-80.
3. Barron J.J., Quimbo R., Nikam P.T., Amonkar M.M. Assessing the economic burden of breast cancer in a US managed care population. Breast Cancer Res. Treat. 2008, 109:367-377.
4. Utrera-Barillas M.D., Castro-Manrreza M.E., Gutierrez-Rodriguez M., Benitez-Bribiesca L. Cancer lymphangiogenesis and its role in metastasic dissemination. Gac. Med. Mex. 2009, 145:51-60.
5. Wang G.L., Wang M.Y., Wei W.B. Clinical features and treatment of choroidal metastasis. Zhonghua Yan Ke Za Zhi. 2009, 45:229-233.
6. Ozdemir H., Tuncbilek G. Metastasis of carcinoma of the uterine cervix to the nasal dorsum. J. Cran. Surg. 2009, 20:971-973.
7. Klein C.A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 2009, 9:302-312.
8. Wittekind C., Neid M. Cancer invasion and metastasis. Oncology 2005, 69(Suppl. 1):14-16.
9. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3:453-458.
10. Nathoo N., Chahlavi A., Barnett G.H., Toms S.A. Pathobiology of brain metastases. J. Clin. Pathol. 2005, 58:237-242.
11. Roodman G.D. Mechanisms of bone metastasis. N. Engl. J. Med. 2004, 350:1655-1664.
12. Wan W., Zou H., Sun R., Liu Y., Wang J., Ma D., Zhang N. Investigate the role of PTEN in chemotaxis of human breast cancer cells. Cell. Signal. 2007, 19:2227-2236.
13. Liu Y., Wang B., Wang J., Wan W., Sun R., Zhao Y., Zhang N. Down-regulation of PKC zeta expression inhibits chemotaxis signal transduction in human lung cancer cells. Lung Cancer 2009, 63:210-218.
14. Suzuki M., Kimijima I., Ishii M. Combination treatment with trastuzumab and Paclitaxel as primary therapy for advanced breast cancer. Gan To Kagaku Ryoho. 2009, 36:1519-1523.
15. Okita A., Saeki T., Aogi K., Osumi S., Takashima S., Okita R., Taira N., Kakishita T., Kurita A. Efficacy and tolerability of weekly Paclitaxel in combination with high-dose toremifene citrate in patients with metastatic breast cancer. Acta Med. Okayama 2009, 63:187-194.
16. Susnjar S., Bosnjak S.M., Radulovic S. Severe skin toxicity observed with the combination of capecitabine and weekly Paclitaxel in metastatic breast cancer patients. Support. Care Cancer 2008, 16:1415-1418.
17. Lee J., Hong J., Nam T.G., Peters E.C., Orth A.P., Geierstanger B.H., Goldfinger L.E., Ginsberg M.H., Cho C.Y., Schultz P.G. A small molecule inhibitor of alpha4 integrin-dependent cell migration. Bioorg. Med. Chem. 2009, 17:977-980.
18. Xin Z.F., Kim Y.K., Jung S.T. Risedronate inhibits human osteosarcoma cell invasion. J. Exp. Clin. Cancer Res. 2009, 28:105.
19. Aoki T., Ueda S., Kataoka T., Satoh T. Regulation of mitotic spindle formation by the RhoA guanine nucleotide exchange factor ARHGEF10. BMC Cell Biol. 2009, 10:56.
20. Sun R., Gao P., Chen L., Ma D., Wang J., Oppenheim J.J., Zhang N. Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res. 2005, 65:1433-1441.
21. 2+-independent protein kinase Cs mediate heterologous desensitization of leukocyte chemokine receptors by opioid receptors. J. Biol. Chem. 2003, 278:12729-12736.
22. Zhang B., Ma Y., Guo H., Sun B., Niu R., Ying G., Zhang N. Akt2 is required for macrophage chemotaxis. Eur. J. Immunol. 2009, 39:894-901.
23. Guo Y.H., Gao W., Li Q., Li P.F., Yao P.Y., Chen K. Tissue inhibitor of metalloproteinases-4 suppresses vascular smooth muscle cell migration and induces cell apoptosis. Life Sci. 2004, 75:2483-2493.
24. Pixley F.J., Lee P.S., Condeelis J.S., Stanley E.R. Protein tyrosine phosphatase phi regulates paxillin tyrosine phosphorylation and mediates colony-stimulating factor 1-induced morphological changes in macrophages. Mol. Cell. Biol. 2001, 21:1795-1809.
25. Kang Y., Zhang X., Jiang W., Wu C., Chen C., Zheng Y., Gu J., Xu C. Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine. BMC Cancer 2009, 9:126.
26. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., Horwitz A.R. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709.
27. Ivanciu L., Gerard R.D., Tang H., Lupu F., Lupu C. Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2007, 27:310-316.
28. Zhang Y., Ma B., Fan Q. Mechanisms of breast cancer bone metastasis. Cancer Lett. 2010, 292:1-7.
29. Olkhanud P.B., Baatar D., Bodogai M., Hakim F., Gress R., Anderson R.L., Deng J., Xu M., Briest S., Biragyn A. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res. 2009, 69:5996-6004.
30. Sotiropoulou E., Valsamaki P., Tsiouris S., Ptohis N., Papantoniou V. Brain metastasis from breast cancer detected by 99mTc (V) DMSA SPET scintigraphy. Hell J. Nucl. Med. 2009, 12:71.
31. Ma J., Li F., Liu L., Cui D., Wu X., Jiang X., Jiang H. Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells. Liver Int. 2009, 29:567-574.
32. Zhang X.H., Wang Q., Gerald W., Hudis C.A., Norton L., Smid M., Foekens J.A., Massague J. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 2009, 16:67-78.
33. Kondo N.I., Yoshida S., Kajiyama H., Nagasaka T., Uematsu T. Metastasis of breast cancer to a uterine leiomyoma. Breast Cancer 2009, 16:157-161.
34. Luo M., Guan J.L. Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett. 2009.
35. Liu Y., Wang J., Wu M., Wan W., Sun R., Yang D., Sun X., Ma D., Ying G., Zhang N. Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells. Mol. Cancer Res. 2009, 7:944-954.
36. Suzuki S.O., Goldman J.E. Multiple cell populations in the early postnatal subventricular zone take distinct migratory pathways: a dynamic study of glial and neuronal progenitor migration. J. Neurosci. 2003, 23:4240-4250.
37. Farin A., Suzuki S.O., Weiker M., Goldman J.E., Bruce J.N., Canoll P. Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia 2006, 53:799-808.